Healthcare ❯ Pharmaceuticals ❯ Drug Development ❯ Clinical Trials

Regulatory Approval

Amazon’s $200 Billion AI Push Draws Analyst Backing Even as Shares Lag

Analysts highlight fast-growing AWS AI revenue, reinforcing bullish calls.

FDA Grants Accelerated Approval to Forzinity, First Therapy for Barth Syndrome

FDA Approves Yeztugo, Twice-Yearly HIV Prevention Injection